EA202190071A1 - ANTIBODIES TO PD-1 AND THEIR APPLICATION - Google Patents

ANTIBODIES TO PD-1 AND THEIR APPLICATION

Info

Publication number
EA202190071A1
EA202190071A1 EA202190071A EA202190071A EA202190071A1 EA 202190071 A1 EA202190071 A1 EA 202190071A1 EA 202190071 A EA202190071 A EA 202190071A EA 202190071 A EA202190071 A EA 202190071A EA 202190071 A1 EA202190071 A1 EA 202190071A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibodies
application
bind
methods
antibody fragments
Prior art date
Application number
EA202190071A
Other languages
Russian (ru)
Inventor
Марк Корнфелд
Наимиш Бхарат Пандя
Джон Марк УИГГИНТОН
Росс Ла Мотте-Мос
Брэдли Джеймс Самроу
Original Assignee
Инсайт Корпорейшн
Макродженикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Инсайт Корпорейшн, Макродженикс, Инк. filed Critical Инсайт Корпорейшн
Priority claimed from PCT/US2019/037750 external-priority patent/WO2019246110A1/en
Publication of EA202190071A1 publication Critical patent/EA202190071A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Описаны способы лечения злокачественного новообразования антителами и фрагментами антител, которые связываются с PD-1.Described are methods of treating cancer with antibodies and antibody fragments that bind to PD-1.

EA202190071A 2018-11-06 2019-06-18 ANTIBODIES TO PD-1 AND THEIR APPLICATION EA202190071A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862756319P 2018-11-06 2018-11-06
PCT/US2019/037750 WO2019246110A1 (en) 2018-06-20 2019-06-18 Anti-pd-1 antibodies and uses thereof

Publications (1)

Publication Number Publication Date
EA202190071A1 true EA202190071A1 (en) 2021-04-01

Family

ID=75817430

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190071A EA202190071A1 (en) 2018-11-06 2019-06-18 ANTIBODIES TO PD-1 AND THEIR APPLICATION

Country Status (1)

Country Link
EA (1) EA202190071A1 (en)

Similar Documents

Publication Publication Date Title
PH12020552221A1 (en) Anti-pd-1 antibodies and uses thereof
EA202090104A1 (en) ANTIBODY MOLECULES TO CD73 AND WAYS OF THEIR APPLICATION
JOP20200078A1 (en) Antibodies specific to CD47 and PD-L1
EA202091888A1 (en) VARIABLE ANTIBODY DOMAINS TARGETED ON THE NKG2D RECEPTOR
SA522431756B1 (en) TIGIT antibodies to
EA201890222A1 (en) POLYSPECIFIC ANTIGENSORATING MOLECULES AND THEIR APPLICATIONS
EA202092668A1 (en) ANTIBODIES TO IL-11
EA202092605A1 (en) ANTIBODIES TO IL-11RA
MX2022002682A (en) ANTI-CD73 ANTIBODIES.
EA202090812A1 (en) NEW BISPECIFIC POLYPEPTIDE COMPLEXES
EA201891709A1 (en) ANTIGENSBINKING PROTEINS, BINDING PD-L1
CL2018000502A1 (en) Bispecific antibodies for pd1 and tim3 useful as immunomodulators or in the treatment of cancer.
EA201990243A1 (en) NEW ANTIBODIES THAT ARE SPECIFICALLY CONNECTED WITH EPIC EPITHOS OF THE ZIKA VIRUS, AND THEIR APPLICATION
EA201691824A1 (en) ANTIBODIES AGAINST EGFRVIII AND THEIR APPLICATIONS
EA201691858A1 (en) ANTIBODY COMPOSITIONS FOR TREATMENT OF TUMORS
MX2022014463A (en) Antigen binding constructs to target molecules.
JOP20220161A1 (en) An anti-LILRB1 antibody and its uses
EA201992460A1 (en) BTLA ANTIBODY ANTIBODIES AND THEIR APPLICATION
EA202090559A1 (en) MULTI-SPECIFIC ANTIBODIES SPECIFIC REGARDING ZIKA VIRUS EPITOPES AND THEIR APPLICATION
EA201992206A1 (en) MONOCLONAL ANTIBODY TO PD-L1
EA202092420A1 (en) ANTIBODY AGAINST PD-L1 AND ITS APPLICATION
EA201990894A1 (en) ANTI-PD-1 / ANTI-HER2 HETERODIMERIC BASPECIFIC ANTIBODY WITH NATURAL ANTIBODY STRUCTURE AND METHOD FOR ITS PRODUCTION
EA201892096A1 (en) NEUTRALIZING MONOCLONAL ANTIBODIES TO IL-25 AND THEIR APPLICATION
PH12020551968A1 (en) Anti-sez6 antibody drug conjugates and methods of use
EA201691414A1 (en) ANTIBODIES TO MATRIX METALLOPROTEINASE 9 AND METHODS OF THEIR APPLICATION